| Historic (2004-11-01 to
2009-06-03) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
cholesterol
|
11730 |
134725.3 |
  |
| 2 |
Zetia
|
10310 |
126931.2 |
  |
| 3 |
Zocor
|
6670 |
83326.2 |
  |
| 4 |
Merck
|
6650 |
79923.7 |
  |
| 5 |
Schering-Plough
|
4460 |
56307.1 |
  |
| 6 |
Schering-Plough Corp.
|
2090 |
30890.5 |
  |
| 7 |
cancer
|
2410 |
29342.2 |
  |
| 8 |
Merck & Co.
|
1540 |
22803.8 |
  |
| 9 |
LDL
|
1220 |
16783.1 |
  |
| 10 |
FDA
|
1110 |
14501.1 |
  |
| 11 |
heart disease
|
870 |
12474.5 |
  |
| 12 |
ENHANCE
|
780 |
11730.6 |
  |
| 13 |
Crestor
|
730 |
11265.7 |
  |
| 14 |
Lipitor
|
730 |
11037.5 |
  |
| 15 |
Schering-Plough Corp
|
640 |
10488.5 |
  |
|
| 365 days (2008-06-03 to
2009-06-03) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
cholesterol
|
2830 |
33015.6 |
  |
| 2 |
cancer
|
2410 |
26260.9 |
  |
| 3 |
Zetia
|
1970 |
25386.5 |
  |
| 4 |
Merck
|
1320 |
16785.2 |
  |
| 5 |
Zocor
|
1230 |
16331.2 |
  |
| 6 |
Schering-Plough
|
1120 |
14696.6 |
  |
| 7 |
Merck & Co.
|
540 |
7741.2 |
  |
| 8 |
FDA
|
430 |
5964.3 |
  |
| 9 |
Schering-Plough Corp.
|
360 |
5352.1 |
  |
| 10 |
Terje Pedersen
|
360 |
5130.5 |
  |
| 11 |
Oslo
|
280 |
4321.9 |
  |
| 12 |
New England Journal
|
290 |
4128.1 |
  |
| 13 |
Bart Stupak
|
260 |
4011.5 |
  |
| 14 |
Medicine
|
280 |
3866.8 |
  |
| 15 |
Norway
|
250 |
3653.3 |
  |
|
| 30 days (2009-05-04 to
2009-06-03) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Zocor
|
30 |
525.8 |
  |
| 2 |
cholesterol
|
30 |
498.4 |
  |
| 3 |
Lipitor
|
10 |
179.3 |
  |
| 4 |
|
0 |
0 |
  |
| 5 |
|
0 |
0 |
  |
| 6 |
|
0 |
0 |
  |
| 7 |
|
0 |
0 |
  |
| 8 |
|
0 |
0 |
  |
| 9 |
|
0 |
0 |
  |
| 10 |
|
0 |
0 |
  |
| 11 |
|
0 |
0 |
  |
| 12 |
|
0 |
0 |
  |
| 13 |
|
0 |
0 |
  |
| 14 |
|
0 |
0 |
  |
| 15 |
|
0 |
0 |
  |
|